🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Dedifferentiated Liposarcoma

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma NCT05607095Phase 12 sites📍 Harrison📍 New York Memorial Sloan Kettering Cancer Center · Tests: Lifileucel (LN-144/LN-145) A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma NCT06843967Phase 1, Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mirdametinib, Palbociclib NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272Phase 1, Phase 27 sites📍 Atlanta📍 Chicago📍 Baton Rouge St. Jude Children's Research Hospital · Tests: Surgical resection, Proton beam radiation therapy, Pazopanib, Ifosfamide, Doxorubicin A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas NCT06025747Phase 11 site📍 Seattle University of Washington · Tests: Abemaciclib, Computed Tomography, Magnetic Resonance Imaging, Radiation Therapy, Therapeutic Surgical Procedure Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas NCT06422806Phase 3269 sites📍 Phoenix📍 Tucson📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Diagnostic Imaging Testing, Doxorubicin, Echocardiography Test, Multigated Acquisition Scan A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. NCT05944224Phase 1, Phase 216 sites📍 Fuzhou📍 Guangzhou📍 Zhengzhou Shanghai Pharmaceuticals Holding Co., Ltd · Tests: SPH4336, Cadonilimab A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172Phase 110 sites📍 Beverly Hills📍 Santa Monica📍 Houston Epkin · Tests: OKN4395, Pembrolizumab, Fasting, Fed, H2 Receptor Antagonist A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma NCT07741877Phase 22 sites📍 Tampa📍 New York Iovance Biotherapeutics, Inc. · Tests: Lifileucel A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) NCT06389799Phase 24 sites📍 Oslo📍 Gothenburg📍 Lund Lund University Hospital · Tests: Pemigatinib, Retifanlimab STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas NCT06975293Phase 1, Phase 214 sites📍 San Francisco📍 Miami📍 Boston STORM Therapeutics LTD · Tests: STC-15 in combination with toripalimab, STC-15 monotherapy Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648Phase 1, Phase 21 site📍 Houston National Cancer Institute (NCI) · Tests: Abemaciclib, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Docetaxel Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Observational Translational Study Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma NCT05711615Phase 116 sites📍 Los Angeles📍 Los Angeles📍 Aurora National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors NCT06578624Phase 1, Phase 23 sites📍 Canton📍 Cleveland📍 Cleveland Lamassu Bio Inc · Tests: SA53-OS (phase 1), SA53-OS (phase 2)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy